DNA binding activity studies and computational approach of mutant SRY in patients with 46, XY complete pure gonadal dysgenesis
- Irene Sánchez-Morenoa(Author),
- Patricia Cantoa(Author),
- Patricia Munguíaa(Author),
- ,
- Bulmaro Cisnerosc(Author),
- Felipe Vilchisb(Author)
- aInstituto Mexicano del Seguro Social,
- bInstituto Nacional de la Nutricion Salvador Zubiran,
- cCentro de Investigacion y de Estudios Avanzados
Publication metrics
Metrics
PlumX, opens in new tab
Abstract
Mutations of SRY are the cause of 46,XY complete pure gonadal dysgenesis (PGD) in 10-15% of patients. In this study, DNA was isolated and sequenced from blood leukocytes and from paraffin-embedded gonadal tissue in five patients with 46,XY complete PGD. DNA binding capability was analyzed by three different methods. The structure of the full length SRY and its mutant proteins was carried out using a protein molecular model. DNA analysis revealed two mutations and one synonymous polymorphism: in patient #4 a Y96C mutation, and a E156 polymorphism; in patient #5 a S143G mosaic mutation limited to gonadal tissue. We demonstrated, by all methods used, that both mutant proteins reduced SRY DNA binding activity. The three-dimensional structure of SRY suggested that besides the HMG box, the carboxy-terminal region of SRY interacts with DNA. In conclusion, we identified two SRY mutations and a polymorphism in two patients with 46,XY complete PGD, demonstrating the importance of the carboxy-terminal region of SRY in DNA binding activity.
Publication Information
Output type
Original language
EnglishPages from-to (Number of pages)
Pages 212-218 (7 pages)Journal (Volume, Issue Number)
Molecular and Cellular Endocrinology (Volume 299, Issue 2)Publication milestones
- Published - 27/02/2009
Publication status
ISSN
0303-7207External Publication IDs
- Scopus: 58649083453
- WOS: 000263662500010
